Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Ductal Infiltrating Metastatic Breast Cancer|Hormone-receptors Positive Breast Cancer
Interventions: BIOLOGICAL: Circulating tumor cells counting at baseline
Sponsor: Institut Curie